From the Journals

If doctors recommend it, teens are more likely to get HPV vaccine


 

FROM PAPILLOMAVIRUS RESEARCH

Physician recommendation was the most common reason parents began human papillomavirus (HPV) vaccination for their adolescents, Brandon Brown, PhD, at the University of California, Riverside, and his associates said.

In a year-long survey of 200 parents’ reasons for agreeing or refusing initial HPV vaccination following practitioner recommendation in a California pediatric practice of six pediatricians, 82% of parents accepted initiation of the HPV series. A significantly higher percentage of parents of male teens did so, compared with parents of female teens (89% vs. 71%; P less than .01), but there were more male children (61.5%) among offspring of the study participants.

National Cancer Institute
Among the parents who accepted HPV vaccination of their teen, strength of the provider recommendation was both the most common (84%) and the most influential (48%) reason they did so. The second most influential reason was related to publicity around the importance of the HPV vaccine (21.5%).

Among parents who refused initiation of the HPV vaccine for their adolescents, the most common reason for refusing (53%) and most influential reason (49%) was “I want to learn more about this vaccine,” while 25% said their child was too young to get the vaccine. Some in this latter group said they would vaccinate their child when they were older.

Of the 195 parents who answered a question regarding whether they had a friend or family member diagnosed with cervical cancer, 13% said yes. Of these parents, 92% agreed to have their child get the HPV vaccine.

Read more at Papillomavirus Research (2017 Jan 17. doi: 10.1016/j.pvr.2017.01.002).

Recommended Reading

Factors tied to parents’ intent to vaccinate teens for HPV
MDedge Infectious Disease
Investigational flu vaccine finds way around pyrogenicity problem
MDedge Infectious Disease
Earlier childhood measles vaccination elevates the risk of vaccine failure
MDedge Infectious Disease
Hexavalent DTaP5-IPV-HB-Hib is immunogenic in series with pentavalent vaccine
MDedge Infectious Disease
Vaccine delivery costs challenge physicians
MDedge Infectious Disease
Measles immunization is a major challenge in HIV-infected children
MDedge Infectious Disease
MMR vaccine cut hospitalizations for unrelated respiratory infections
MDedge Infectious Disease
Consider college immunization requirements when counseling about vaccines
MDedge Infectious Disease
Dengue vaccine appears safe, immunogenic in children aged 2-17 years
MDedge Infectious Disease
ACIP approves new hepatitis A vaccine draft recommendations
MDedge Infectious Disease